Personalis to Participate at the TD Cowen 3rd Annual Tools / Dx Revolution Conference

Rhea-AI Summary

Personalis (Nasdaq: PSNL), a leader in advanced genomics for cancer, announced that its CEO and President, Chris Hall, will participate in the TD Cowen 3rd Annual Tools / Dx Revolution Conference.

Scheduled for June 25, 2024, at 5:30 p.m. Eastern Time, Hall will join a panel discussion, highlighting Personalis' innovative contributions to the genomics and diagnostics sectors.

FREMONT, Calif.--(BUSINESS WIRE)-- Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, announced today that Chris Hall, CEO and President, will join a panel and speak at the TD Cowen 3^rd Annual Tools / Dx Revolution Conference on Tuesday, June 25, 2024 at 5:30 p.m. Eastern Time.

About Personalis, Inc.

At Personalis, we are transforming the active management of cancer through breakthrough personalized testing. We aim to drive a new paradigm for cancer management, guiding care from biopsy through the life of the patient. Our highly sensitive assays combine tumor-and-normal profiling with proprietary algorithms to deliver advanced insights even as cancer evolves over time. Our products are designed to detect minimal residual disease (MRD) and recurrence at the earliest timepoints, enable the selection of targeted therapies based on ultra-comprehensive genomic profiling, and enhance biomarker strategy for drug development. Personalis is based in Fremont, California. To learn more, visit www.personalis.com and connect with us on LinkedIn and X (Twitter).

View source version on businesswire.com: https://www.businesswire.com/news/home/20240618438450/en/

Investors:

Caroline Corner

investors@personalis.com

415-202-5678

Media Contact:

pr@personalis.com

Source: Personalis, Inc.

FAQ

What is the date and time of Personalis' participation in the TD Cowen 3rd Annual Tools / Dx Revolution Conference?

Personalis' CEO and President, Chris Hall, will participate on June 25, 2024, at 5:30 p.m. Eastern Time.

Who from Personalis is speaking at the TD Cowen 3rd Annual Tools / Dx Revolution Conference?

Chris Hall, the CEO and President of Personalis, will be speaking at the conference.

What is the focus of the TD Cowen 3rd Annual Tools / Dx Revolution Conference?

The conference focuses on advancements in tools and diagnostics, with a specific emphasis on genomics.

How is Personalis contributing to the TD Cowen 3rd Annual Tools / Dx Revolution Conference?

Personalis is contributing through a panel discussion led by its CEO, Chris Hall, highlighting their genomics innovations.

What is Personalis' stock symbol on Nasdaq?

Personalis' stock symbol on Nasdaq is PSNL.